• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

Introduction to 1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid, 3-bromo-, methyl ester (CAS No. 913181-71-2)

1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid, 3-bromo-, methyl ester, identified by the CAS number 913181-71-2, is a structurally intriguing heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyrrolopyridine class, a scaffold that is widely recognized for its biological activity and potential therapeutic applications. The presence of a bromo substituent at the 3-position and an ester group at the 2-position introduces unique electronic and steric properties, making it a valuable intermediate in the synthesis of more complex molecules.

The pyrrolo[2,3-b]pyridine core is a fused bicyclic system consisting of a pyrrole ring and a pyridine ring, which is known to exhibit diverse biological activities. These include antimicrobial, anti-inflammatory, antiviral, and anticancer properties. The bromo substitution at the 3-position enhances the reactivity of the molecule, allowing for further functionalization through cross-coupling reactions such as Suzuki-Miyaura or Buchwald-Hartwig couplings. This makes 1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid, 3-bromo-, methyl ester a versatile building block for the development of novel pharmacophores.

The methyl ester functionality at the 2-position provides an additional handle for chemical modification. Ester groups are commonly used in medicinal chemistry due to their ease of hydrolysis under acidic or basic conditions, allowing for the introduction of other functional groups such as carboxylic acids or amides. This feature is particularly useful in library synthesis and drug discovery efforts where diversification of the molecular structure is essential.

In recent years, there has been growing interest in 1H-pyrrolo[2,3-b]pyridine derivatives due to their potential applications in treating various diseases. For instance, studies have shown that certain pyrrolopyridines exhibit inhibitory activity against kinases, which are key enzymes involved in cancer cell proliferation. The bromo substituent in this compound can be selectively modified to introduce other bioactive moieties, enabling the development of targeted therapeutics.

One notable area of research involving 1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid, 3-bromo-, methyl ester is its role as a precursor in the synthesis of small-molecule inhibitors for protein-protein interactions. These interactions are critical in many biological pathways and are often implicated in diseases such as cancer and inflammation. By designing molecules that disrupt these interactions, researchers aim to develop novel therapeutic strategies.

The synthetic utility of this compound is further highlighted by its application in generating libraries of diverse scaffolds for high-throughput screening. The combination of the bromo and ester functionalities allows for orthogonal chemical transformations, enabling the rapid assembly of complex structures with minimal interference between functional groups.

Recent advances in computational chemistry have also facilitated the design of more effective derivatives of 1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid, 3-bromo-, methyl ester. By leveraging machine learning algorithms and molecular docking techniques, researchers can predict the binding affinity and selectivity of different analogs before conducting experimental synthesis. This approach has significantly accelerated the drug discovery process and has led to the identification of several promising lead compounds.

The pharmacokinetic properties of this compound are also under investigation. Understanding how a molecule behaves in vivo is crucial for its development into a viable drug candidate. Studies have focused on optimizing solubility, metabolic stability, and distribution profiles to enhance bioavailability and reduce toxicity.

In conclusion,1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid, 3-bromo-, methyl ester (CAS No. 913181-71-2) represents a fascinating example of how structural modifications can influence biological activity. Its unique combination of functional groups makes it a valuable tool in synthetic chemistry and drug discovery. As research continues to uncover new applications for this compound and its derivatives,1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid, bromo substitution, and methyl ester functionalities will undoubtedly play a pivotal role in shaping the future of medicinal chemistry.

• 1234616-83-1(Methyl 5-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate)
• 942920-55-0(Ethyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate)
• 1204475-66-0(1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid, 3-bromo-)
• 61830-10-2(2,6-Pyridinedicarboxylic acid, 3,5-dibromo-, dimethyl ester)
• 220664-31-3(Methyl 3-bromo-1H-indole-2-carboxylate)
• 316808-11-4(Dimethyl 3-bromopyridine-2,6-dicarboxylate)
• 952800-37-2(methyl 3-bromo-6-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate)
• 1333509-23-1(Methyl 6,8-dibromoimidazo[1,2-a]pyridine-5-carboxylate)
• 1190322-26-9(5-Bromo-1H-pyrrolo[2,3-b]pyridine-6-carboxylic acid)
• 1222175-21-4(Ethyl 5-Bromo-1H-pyrrolo2,3-bpyridine-2-carboxylate)